140 related articles for article (PubMed ID: 8898251)
21. Laryngeal electromyographic activity in adductor and abductor spasmodic dysphonia.
Watson BC; Schaefer SD; Freeman FJ; Dembowski J; Kondraske G; Roark R
J Speech Hear Res; 1991 Jun; 34(3):473-82. PubMed ID: 2072670
[TBL] [Abstract][Full Text] [Related]
22. Electroglottographic tracking of phonatory response to Botox.
Fisher KV; Scherer RC; Swank PR; Giddens C; Patten D
J Voice; 1999 Jun; 13(2):203-18. PubMed ID: 10442750
[TBL] [Abstract][Full Text] [Related]
23. Botulinum toxin therapy for abductor spasmodic dysphonia.
Woodson G; Hochstetler H; Murry T
J Voice; 2006 Mar; 20(1):137-43. PubMed ID: 16126369
[TBL] [Abstract][Full Text] [Related]
24. Outcomes assessment following treatment of spasmodic dysphonia with botulinum toxin.
Courey MS; Garrett CG; Billante CR; Stone RE; Portell MD; Smith TL; Netterville JL
Ann Otol Rhinol Laryngol; 2000 Sep; 109(9):819-22. PubMed ID: 11007083
[TBL] [Abstract][Full Text] [Related]
25. Effects of botulinum toxin injections on speech in adductor spasmodic dysphonia.
Ludlow CL; Naunton RF; Sedory SE; Schulz GM; Hallett M
Neurology; 1988 Aug; 38(8):1220-5. PubMed ID: 3399071
[TBL] [Abstract][Full Text] [Related]
26. Increased stability of airflow following botulinum toxin injection.
Finnegan EM; Luschei ES; Gordon JD; Barkmeier JM; Hoffman HT
Laryngoscope; 1999 Aug; 109(8):1300-6. PubMed ID: 10443837
[TBL] [Abstract][Full Text] [Related]
27. The use of botulinum toxin in the treatment of adductor spasmodic dysphonia.
Whurr R; Lorch M; Fontana H; Brookes G; Lees A; Marsden CD
J Neurol Neurosurg Psychiatry; 1993 May; 56(5):526-30. PubMed ID: 8505645
[TBL] [Abstract][Full Text] [Related]
28. Botulinum toxin treatment for spasmodic dysphonia.
Kobayashi T; Niimi S; Kumada M; Kosaki H; Hirose H
Acta Otolaryngol Suppl; 1993; 504():155-7. PubMed ID: 8470525
[TBL] [Abstract][Full Text] [Related]
29. Unilateral versus bilateral thyroarytenoid Botulinum toxin injections in adductor spasmodic dysphonia: a prospective study.
Upile T; Elmiyeh B; Jerjes W; Prasad V; Kafas P; Abiola J; Youl B; Epstein R; Hopper C; Sudhoff H; Rubin J
Head Face Med; 2009 Oct; 5():20. PubMed ID: 19852852
[TBL] [Abstract][Full Text] [Related]
30. Identification of symptoms for spasmodic dysphonia and vocal tremor: a comparison of expert and nonexpert judges.
Barkmeier JM; Case JL; Ludlow CL
J Commun Disord; 2001; 34(1-2):21-37. PubMed ID: 11322567
[TBL] [Abstract][Full Text] [Related]
31. Botulinum toxin in the treatment of adductor spasmodic dysphonia.
Thompson AR
J Ark Med Soc; 1994 Jan; 90(8):383-5. PubMed ID: 8175618
[TBL] [Abstract][Full Text] [Related]
32. Botulinum toxin for the treatment of spasmodic dysphonia.
Gibbs SR; Blitzer A
Otolaryngol Clin North Am; 2000 Aug; 33(4):879-94. PubMed ID: 10918666
[TBL] [Abstract][Full Text] [Related]
33. [Indications for botulinum toxin in laryngectomy].
Klap P; Marion MH; Perrin A; Fresnel-Elbaz E; Cohen M
Rev Laryngol Otol Rhinol (Bord); 1993; 114(4):281-7. PubMed ID: 8029549
[TBL] [Abstract][Full Text] [Related]
34. A comparison of methods of botulinum toxin injection for abductory spasmodic dysphonia.
Meleca RJ; Hogikyan ND; Bastian RW
Otolaryngol Head Neck Surg; 1997 Nov; 117(5):487-92. PubMed ID: 9374172
[TBL] [Abstract][Full Text] [Related]
35. Teaching video NeuroImage: Spasmodic dysphonia: adductor and abductor.
Reich SG; Meyer T
Neurology; 2008 May; 70(19):e78. PubMed ID: 18458222
[No Abstract] [Full Text] [Related]
36. Longitudinal effects of botulinum toxin injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia.
Hogikyan ND; Wodchis WP; Spak C; Kileny PR
J Voice; 2001 Dec; 15(4):576-86. PubMed ID: 11792036
[TBL] [Abstract][Full Text] [Related]
37. Analysis of factors affecting botulinum toxin results in spasmodic dysphonia.
Inagi K; Ford CN; Bless DM; Heisey D
J Voice; 1996 Sep; 10(3):306-13. PubMed ID: 8865102
[TBL] [Abstract][Full Text] [Related]
38. Spasmodic dysphonia: let's look at that again.
Murry T
J Voice; 2014 Nov; 28(6):694-9. PubMed ID: 24972536
[TBL] [Abstract][Full Text] [Related]
39. Unilateral versus bilateral botulinum toxin injections in adductor spasmodic dysphonia.
Langeveld TP; Drost HA; Baatenburg de Jong RJ
Ann Otol Rhinol Laryngol; 1998 Apr; 107(4):280-4. PubMed ID: 9557760
[TBL] [Abstract][Full Text] [Related]
40. Perceptual-acoustic relationships in spasmodic dysphonia.
Zwirner P; Murry T; Woodson GE
J Voice; 1993 Jun; 7(2):165-71. PubMed ID: 8353631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]